Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

NorthStar Medical Radioisotopes, LLC and Convergent Therapeutics, Inc. Sign Strategic Contract Manufacturing Services Agreement Around CONV01-α

Aug 13, 2024•almost 2 years ago

Contract Type

contract

BeloitBiotechnologyHealth CareMedicalMedical Device

Description

NorthStar Medical Radioisotopes, LLC and Convergent Therapeutics, Inc. have announced the signing of a strategic contract manufacturing services agreement. This expanded collaboration will support clinical trials for CONV01-α, a prostate-specific membrane antigen (PSMA)-targeted monoclonal antibody linked to Ac-225, currently being investigated as a treatment for prostate cancer.

Company Information

Company

NorthStar Medical Technologies

Location

Beloit, Wisconsin, United States

About

NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, is a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for NorthStar Medical Technologies's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.